Beacon DDR

How the most complete clinical trial and drug landscape for DDR can help you

What we cover

Beacon DNA Damage Response (DDR) covers trial and drug records for clinical, preclinical, approved and discontinued therapeutics targeting key points in DNA damage response pathways.  

This module identifies drugs utilizing the concept of synthetic lethality, and covers DDR repair pathway components, including: 

  • Damage Sensors  
  • Signalling/Mediator Proteins  
  • Effector Proteins  
  • Cell Cycle Checkpoints  
  • DNA Metabolism when in relation to repair and recombination  

Several key therapeutic targets in the DDR landscape included in this module are: 

  • PARP  
  • ATM  
  • ATR  
  • CHK1/2  
  • WEE1  
  • DNA-PK 

How Beacon helps

Here are some examples of how Beacon DDR can accelerate your research programs:

  • Search for DDR drugs across all stages of development so you can accurately benchmark your strategies against other preclinical and clinical drugs, and investigate the novel approaches used by competitors.
  • Drastically reduce time spent looking through publications and conference abstracts for clinical trial results by relying on our comprehensive collection of data which can be searched by disease, combination treatments and much more.
  • Stay on top of emerging trends and new players in the field with real-time updates and alerts, as well as in-depth monthly reports curated by our expert analyst team.

How Beacon DDR works

Search the trial and drug landscape by target, repair pathway and mechanism of action alongside 15 other search criteria including disease, line of therapy, biomarker, sponsor etc. to instantly extract the data points you need to conduct more complex analysis.

How we target the data for DNA damage repair therapeutics

We house all publicly available sources of data updated with 24 – 48 hours of publication proactively.  Our sources cover (but are not limited to):

  • Clinical trials registries
  • Scientific journals and publications
  • Company reports and presentations
  • Press releases
  • Conference reports and abstracts
  • Government and regulatory organizations
  • Newspapers and other media
  • Patents

Related content

DDR Infographic June 2021

Find out more

DDR Infographic 2021

Find out more

What our customers say

Beacon is a great database that people should pay attention to. It's much better than many of the more generic databases that try to capture all data about everything

Director
Top Biotech Company

Our DDR Expert

Charlotte Price, MSc, is the lead research analyst for Beacon DDR in the Beacon Targeted Therapies teams.

Sign up to her weekly newsletter to uncover the latest insights into the DDR landscape using data from Beacon Targeted Therapies.

Subscribe to newsletter

Other Beacon Solutions

ADC
Adoptive Cell
Bispecific
Cancer Vaccine
Checkpoint
Cytokine
Gene Therapy
RNA
Oncolytic Viruses
TPD
Beacon ADC Logo

 

Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates (SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more

Find out more

Beacon Adoptive Cell Logo

 

Covering all engineered and non-engineered immune cell therapies, including CAR-T, TCR, NK, TILs, Gamma-Delta T Cells and more

Find out more

Beacon Bispecific Logo

 

Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented Antibodies and more

Find out more

Cancer Vaccine Logo 2021

 

Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field.

Find out more

Beacon Checkpoint Logo

 

Covering all Immune Checkpoint Combination Trials and Immune Checkpoint Modulators in development across 27 different checkpoint targets

Find out more

 

Covering all cytokines and drugs that target a cytokine or its immediate receptor belonging to the Interleukins, Interferons, Colony-stimulating factors, Transforming growth factor β, Tumour necrosis factor and Chemokines families.

Find out more

Beacon Gene Therapy Logo

 

From gene-editing technologies, novel delivery systems, and a variety of genetic materials being used- Beacon Gene Therapy steps into the field to give drug developers a precise and detailed view of how the gene therapy landscape looks.

Find out more

 

Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.

Find out more

Beacon Oncolytic Viruses Logo

 

From capturing viral family and strains to understanding any genetic modifications – Beacon Oncolytic Viruses steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the Oncolytic Virus field.

Find out more

Beacon TPD Logo

 

Beacon TPD provides the solution you need to master the targeted protein degradation field.

Find out more

Any questions? Contact us

To learn more about how we can tailor Beacon DDR to help you, get in touch with our sales team

Frank Plowden

 

Frank Plowden

DDR Account Manager

Contact the Team

About Beacon Targeted Therapies

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.

logo